Genoway (ALGEN)

Currency in EUR
2.040
-0.030(-1.45%)
Real-time Data·
ALGEN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.0202.050
52 wk Range
2.0102.880
Key Statistics
Prev. Close
2.07
Open
2.05
Day's Range
2.02-2.05
52 wk Range
2.01-2.88
Volume
5.96K
Average Volume (3m)
6.01K
1-Year Change
-25.5474%
Book Value / Share
2.40
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALGEN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Sep 23, 2026
EPS / Forecast
-- / --
Revenue / Forecast
10.29M / --
EPS Revisions
Last 90 days

ALGEN Income Statement

Compare ALGEN to Peers and Sector

Metrics to compare
ALGEN
Peers
Sector
Relationship
P/E Ratio
−8.9x−3.0x−0.3x
PEG Ratio
-0.030.00
Price/Book
0.8x1.1x2.6x
Price / LTM Sales
0.8x9.1x2.8x
Upside (Analyst Target)
-182.7%66.4%
Fair Value Upside
Unlock9.8%9.0%Unlock

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.

Employees
163
Market
France

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
9.59K0.10%19.86K
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
9.21M99.90%19.07M
Total
9.22M100.00%19.09M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
GVC Gaesco Gestion SGIIC SA0.10%9,59420
Fonsvila-Real FI0.10%9,59420

People Also Watch

42.85
STMPA
+2.32%
156.90
IPN
-0.44%
0.075
ALINT
0.00%
1.5660
ABNX
-3.09%

FAQ

What Is the Genoway (ALGEN) Stock Price Today?

The Genoway stock price today is 2.040 EUR.

What Stock Exchange Does Genoway Trade On?

Genoway is listed and trades on the Paris Stock Exchange.

What Is the Stock Symbol for Genoway?

The stock symbol for Genoway is "ALGEN."

What Is the Genoway Market Cap?

As of today, Genoway market cap is 18.810M EUR.

From a Technical Analysis Perspective, Is ALGEN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genoway Stock Split?

Genoway has split 0 times.

How Many Employees Does Genoway Have?

Genoway has 163 employees.

What is the current trading status of Genoway (ALGEN)?

As of Nov 02, 2026, Genoway (ALGEN) is trading at a price of 2.040 EUR, with a previous close of 2.070 EUR. The stock has fluctuated within a day range of 2.020 EUR to 2.050 EUR, while its 52-week range spans from 2.010 EUR to 2.880 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.